Articles by Jennifer Markarian - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jennifer Markarian
« Previous
123456
Next »

IMS Institute for Healthcare Informatics Issues Forecast for Global Medicine Use

Jul 16, 2012
By: Jennifer Markarian

Global spending on medicines is estimated to reach nearly $1.2 trillion by 2016.

ISPE Issues Guidance for Packaging, Labeling, and Warehousing Facilities

Jul 9, 2012
By: Jennifer Markarian

ISPE has issued a guidance that is intended to help companies meet cGMP requirements for packaging, labeling, and warehousing facilities and avoid problems such as product adulteration, product mix-up, label mix-up, and misbranding.

35th Anniversary Special: Breakthroughs and Emerging Technologies in Manufacturing

Industry experts share their insight on solid-dosage and sterile manufacturing.
Jul 2, 2012
By: Jennifer Markarian

Industry experts share their insight on solid-dosage and sterile manufacturing.

Hot-Melt Developments

Developments in hot-melt extrusion using twin-screw extruders to make solid-dosage drug forms.
Jul 2, 2012
By: Jennifer Markarian

Developments in hot-melt extrusion using twin-screw extruders to make solid-dosage drug forms.

Teva Wins Patent-infringement Lawsuit Protecting Copaxone

Jun 25, 2012
By: Jennifer Markarian

US court ruled in favor of Teva in its patent-infringement lawsuit against Momenta and Mylan's generic versions of Teva's Copaxone.

Finding Value in Single-use Systems

Time- and cost-savings benefits help drive increased use of single-use, disposable systems in biopharmaceutical manufacturing.
Jun 20, 2012
By: Jennifer Markarian

Time- and cost-savings benefits help drive increased use of single-use, disposable systems in biopharmaceutical manufacturing.

Pharma Associations Provide Update on Anticounterfeiting Initiatives

Jun 11, 2012
By: Jennifer Markarian

European and US associations call for continued vigilance against the threat of counterfeit medicines.

Human Genome Sciences Rejects GlaxoSmithKline's $2.6 Billion Offer

May 21, 2012
By: Jennifer Markarian

Human Genome Sciences rejects GlaxoSmithKline offer to acquire the company and issues a poison pill to prevent a takeover.

Ongoing Challenges in Continuous Manufacturing

Advances in process analytical technology and in defining lots for release are key for enabling use of continuous processes in solid-dosage manufacturing.
May 16, 2012
By: Jennifer Markarian

Advances in process analytical technology and in defining lots for release are key for enabling use of continuous processes in solid-dosage manufacturing.

« Previous
123456
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here